Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C
Clinical trial NCT02118012 · COMPLETED
Trial details
- NCT number
- NCT02118012
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-20
- Primary completion
- 2014-03-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.